{
    "2021-05-13": [
        [
            {
                "time": "",
                "original_text": "【银河医药孟令伟/刘晖】公司点评丨天坛生物 (600161)：业绩符合预期，看好发展前景",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "业绩",
                        "符合预期",
                        "发展前景"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}